Search research articles
Contact Us
Filters
Showing results (41-50 of 113) with videos related to
Page
of 12
Sort By:
Biological Psychiatry
|
October 27, 2005
Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder
Martin Keller, Stuart Montgomery, William Ball, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 30, 2018
Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
November 7, 2016
Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study
Markus Dold, Alexander Kautzky, Lucie Bartova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 23, 2019
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
May 6, 2019
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Journal of Affective Disorders
|
October 15, 2021
Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study
Markus Dold, Lucie Bartova, Gernot Fugger, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
April 28, 2015
Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample
Leonardo Zaninotto, Daniel Souery, Raffaella Calati, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
October 11, 2022
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting
Fabio Panariello, Siegfried Kasper, Joseph Zohar, et al.
Journal of Affective Disorders
|
June 13, 2015
Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression
Leonardo Zaninotto, Daniel Souery, Raffaella Calati, et al.
Journal of Psychiatric Research
|
July 3, 2021
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 113) with videos related to
Sort By:
Page
of 12
Biological Psychiatry
|
October 27, 2005
Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder
Martin Keller, Stuart Montgomery, William Ball, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 30, 2018
Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
November 7, 2016
Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study
Markus Dold, Alexander Kautzky, Lucie Bartova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 23, 2019
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
May 6, 2019
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Journal of Affective Disorders
|
October 15, 2021
Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study
Markus Dold, Lucie Bartova, Gernot Fugger, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
April 28, 2015
Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample
Leonardo Zaninotto, Daniel Souery, Raffaella Calati, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
October 11, 2022
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting
Fabio Panariello, Siegfried Kasper, Joseph Zohar, et al.
Journal of Affective Disorders
|
June 13, 2015
Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression
Leonardo Zaninotto, Daniel Souery, Raffaella Calati, et al.
Journal of Psychiatric Research
|
July 3, 2021
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Page
of 12